Attachment F

Attachment F_2009 Laboratory Medicine Best Practices Workgroup.doc

Laboratory Medicine Best Practices Project

Attachment F

OMB: 0920-0848

Document [doc]
Download: doc | pdf




2009 Laboratory Medicine Best Practices Workgroup



Raj Behal, MD, MPH

Associate Chief Medical Officer

Senior Patient Safety Officer

Rush University Medical Center


Robert H. Christenson, PhD, DABCC, FACB

Professor of Pathology and Medical and Research Technology, University of Maryland Medical Center


John Fontanesi, PhD

Director, Center for Management Science in Health; Professor of Pediatrics and Family and Preventive Medicine

University of California, San Diego


Julie Gayken, MT(ASCP)

Director of Laboratory Services

Anatomic & Clinical Pathology

Regions Hospital


Cyril (Kim) Hetsko, MD, FACP

Clinical Professor of Medicine, University of Wisconsin-Madison

Chief Medical Officer, COLA

Trustee, American Medical Association


Lee Hilborne, MD, MPH

Professor of Pathology and Laboratory

Medicine, UCLA David Geffen School of Medicine, Center for Patient Safety and Quality, President-Elect, American Society for Clinical Pathology


James Nichols, PhD

Director, Clinical Chemistry

Department of Pathology

Baystate Medical Center

Mary Nix, MS, MT(ASCP)SBB

Project Officer, National Guideline Clearinghouse; National Quality Measures Clearinghouse; Quality Tools; Innovations Clearinghouse

Center for Outcomes and Evidence

Agency for Healthcare Research and Quality


Stephen Raab, MD

Director, Cytopathology Laboratory

University of Colorado Cancer Center


Milenko Tanasijevic, MD, MBA

Director, Clinical Laboratories Division and Clinical Program Development, Pathology Department

Brigham and Women’s Hospital


Ann Vannier, MD

Regional Chief of Laboratory Medicine & Director, Southern California Kaiser Permanente Regional Reference Laboratories


Ann Watt, MBA, RHIA

Project Director

Group on Standardized Performance

Measurement Division of Research

The Joint Commission


Sousan S. Altaie, PhD (ex officio)

Scientific Policy Advisor, Office of In Vitro Diagnostic Device (OIVD)

Evaluation and Safety Center for Devices and Radiological Health

(CDRH), FDA


James A. Cometa (ex officio)

Team Leader/Program Analyst

Centers for Medicare and Medicaid Services (CMS)


Phase 2 Final Report 1

File Typeapplication/msword
File Title2009 Laboratory Medicine Best Practices Workgroup
Authorcgd9
Last Modified Byaeo1
File Modified2009-07-27
File Created2009-07-27

© 2024 OMB.report | Privacy Policy